- Home
- NRXS vs VGI Comparison
NRXS vs VGI Comparison
Compare NRXS & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NRXS | VGI |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.9M | 83.1M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | NRXS | VGI |
|---|---|---|
| Price | $7.43 | $7.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 177.3K | 38.8K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.66% |
| EPS Growth | ★ 22.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,569,282.00 | N/A |
| Revenue This Year | $172.91 | N/A |
| Revenue Next Year | $115.71 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.89 | N/A |
| 52 Week Low | $2.20 | $7.20 |
| 52 Week High | $9.33 | $8.09 |
Technical Indicators
Market Signals| Indicator | NRXS | VGI |
|---|---|---|
| Relative Strength Index (RSI) | 44.43 | 42.00 |
| Support Level | $6.80 | $7.20 |
| Resistance Level | $8.03 | $7.98 |
| Average True Range (ATR) | 0.63 | 0.08 |
| MACD | -0.16 | -0.02 |
| Stochastic Oscillator | 8.97 | 33.33 |
Price Performance
Historical ComparisonAbout NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest
Virtus Global Multi-Sector Inc is a United States based fund. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objective by applying extensive credit research to capitalize on opportunities across undervalued areas of the international bond markets.